(Q34087732)

30 July 2017

The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression (English)

1 reference

ribonucleoprotein complex

30 July 2017

1 reference

P A Pioli

1

1 reference

PubMed ID

11517223

30 July 2017

W F Rigby

series ordinal

2

1 reference

PubMed ID

11517223

30 July 2017

language of work or name

English

0 references

publication date

21 August 2001

1 reference

Journal of Biological Chemistry

30 July 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 July 2017

276

1 reference

30 July 2017

40346-40352

1 reference

30 July 2017

43

1 reference

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype

30 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Mutations of the VHL tumour suppressor gene in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Mutation and cancer: statistical study of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Identification of the von Hippel-Lindau disease tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Tumour suppression by the human von Hippel-Lindau gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Inhibition of transcription elongation by the VHL tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

The von Hippel-Lindau tumour suppressor protein: new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Cell cycle: cull and destroy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Polycythemia: mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Oncogenes in tumor metabolism, tumorigenesis, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Rapid degradation of AU-rich element (ARE) mRNAs is activated by ribosome transit and blocked by secondary structure at any position 5' to the ARE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

GLUT1 glucose transporter: differential gene transcription and mRNA binding to cytosolic and polysome proteins in brain and peripheral tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific expression and novel isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105391200

21 January 2018

Identifiers

DOI

10.1074/JBC.M105391200

1 reference

30 July 2017

1 reference

PubMed ID

11517223